Pablo Melonari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pablo Melonari has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Adriana I. Landa
National Council of Scientific and Technological Research (CONICET), Laboratory of Neurosciences and Experimental Psychology , Ciudad Universitaria, Parque General San Martin , Mendoza , Argentina
1 shared publication Adrián G. Collia
Sanatorio Mater Dei, Provincia de Buenos Aires, República Argentina
1 shared publicationAldo Cancellara
Hospital de Niños Pedro de Elizalde, Provincia de Buenos Aires, República Argentina
1 shared publicationAlejandra Gaiano
Hospital Materno Infantil de San Isidro, Provincia de Buenos Aires, República Argentina
1 shared publicationAlejandro Ellis
Sanatorio Mater Dei, Provincia de Buenos Aires, República Argentina
1 shared publicationAlejandro Santillán
Hospital Interzonal de Niños Eva Perón, Provincia de Catamarca, República Argentina
1 shared publication
Latest Publications
- 29 June 2020
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 31 (6)
Effects of atenolol injected into the nucleus accumbens septi in rats in the elevated plus-maze test
Background: In previous studies, we have observed that glutamate antagonists injected within the nucleus accumbens septi (NAS) induced an anxiolytic-like effect in the elevated plus maze (EPM) test in rats. In the present study, the effect of Atenolol, a specific Beta Adreno-receptor antagonist in the EPM was studied in male rats bilaterally cannulated NAS. Methods: Rats were divided into five groups that received either 1 μL injections of saline or atenolol in different doses (0.75, 1 or 2 μg/1 μL, n=15–16) 15 min before testing. Results: Time Spent in the Open Arm was modified by treatment (F=4.563, p=0.006, df 3). This was increased by the lowest dose of atenolol (p<0.05), by the medium doses (p<0.001) and also by the highest dose (p<0.01). Time per Entry was modified by treatment (F=4.54, p=0.06, df 3). This parameter was increased by the lowest dose of atenolol (p<0.01), but not for the medium and higher doses. Conclusions: We conclude that Atenolol beta receptor blockade in the accumbens lead to an anxiolytic-like effect related to an increase in the time spent in the open arm and in the time per entry, showing specific behavioral patterns.
- 29 June 2020
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 31 (6)
Effects of atenolol injected into the nucleus accumbens septi in rats in the elevated plus-maze test
Background: In previous studies, we have observed that glutamate antagonists injected within the nucleus accumbens septi (NAS) induced an anxiolytic-like effect in the elevated plus maze (EPM) test in rats. In the present study, the effect of Atenolol, a specific Beta Adreno-receptor antagonist in the EPM was studied in male rats bilaterally cannulated NAS. Methods: Rats were divided into five groups that received either 1 μL injections of saline or atenolol in different doses (0.75, 1 or 2 μg/1 μL, n=15–16) 15 min before testing. Results: Time Spent in the Open Arm was modified by treatment (F=4.563, p=0.006, df 3). This was increased by the lowest dose of atenolol (p<0.05), by the medium doses (p<0.001) and also by the highest dose (p<0.01). Time per Entry was modified by treatment (F=4.54, p=0.06, df 3). This parameter was increased by the lowest dose of atenolol (p<0.01), but not for the medium and higher doses. Conclusions: We conclude that Atenolol beta receptor blockade in the accumbens lead to an anxiolytic-like effect related to an increase in the time spent in the open arm and in the time per entry, showing specific behavioral patterns.
- Open Access
- 1 October 2019
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 36 (5) , 636-641
Características clínico-epidemiológicas y predictores de complicaciones coronarias en niños de Argentina con enfermedad de Kawasaki
Palabras clave: Enfermedad de Kawasaki; complicación coronaria; aneurismas coronarios, factores de riesgo coronario
- 1 October 2019
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 36 (5) , 636-641
Open AccessCaracterísticas clínico-epidemiológicas y predictores de complicaciones coronarias en niños de Argentina con enfermedad de Kawasaki
Palabras clave: Enfermedad de Kawasaki; complicación coronaria; aneurismas coronarios, factores de riesgo coronario
- 1 February 2013
- Published by Sociedad Argentina de Pediatria in Archivos Argentinos de Pediatria
- Vol. 111 (1) , e10-e13
Meningoencefalitis por influenza A pH1N1. Presentación de un caso clínico
The influenza virus causes epidemics and pandemics with high morbidity and mortality. According to the World Health Organization, this virus causes 3-5 million cases of severe illness and 250,000 to 500,000 deaths each year. The disease is mainly respiratory and the most common complications are pneumonia, exacerbation of underlying diseases and less frequently respiratory complications. We report a 6-year-old patient with meningoencephalitis due to a new influenza A (IA), strain pH1N1, with viral documentation in cerebrospinal fluid (CSF). We provide detailed clinical, laboratory and imaging of the case, which responded favorably to sequels. Knowledge of this form of presentation is of great clinical and epidemiological significance due to the limited scientific evidence published internationally.
- 1 February 2013
- Published by Sociedad Argentina de Pediatria in Archivos Argentinos de Pediatria
- Vol. 111 (1) , e10-e13
Meningoencefalitis por influenza A pH1N1. Presentación de un caso clínico
The influenza virus causes epidemics and pandemics with high morbidity and mortality. According to the World Health Organization, this virus causes 3-5 million cases of severe illness and 250,000 to 500,000 deaths each year. The disease is mainly respiratory and the most common complications are pneumonia, exacerbation of underlying diseases and less frequently respiratory complications. We report a 6-year-old patient with meningoencephalitis due to a new influenza A (IA), strain pH1N1, with viral documentation in cerebrospinal fluid (CSF). We provide detailed clinical, laboratory and imaging of the case, which responded favorably to sequels. Knowledge of this form of presentation is of great clinical and epidemiological significance due to the limited scientific evidence published internationally.